178 related articles for article (PubMed ID: 32824832)
1. 18F-FDG, 11C-Methionine, and 68Ga-Pentixafor PET/CT in Patients with Smoldering Multiple Myeloma: Imaging Pattern and Clinical Features.
Zhou X; Dierks A; Kertels O; Kircher M; Schirbel A; Samnick S; Buck AK; Knorz S; Böckle D; Scheller L; Messerschmidt J; Barakat M; Kortüm KM; Rasche L; Einsele H; Lapa C
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32824832
[TBL] [Abstract][Full Text] [Related]
2. Chemokine receptor-4 targeted PET/CT with
Pan Q; Cao X; Luo Y; Li J; Feng J; Li F
Eur J Nucl Med Mol Imaging; 2020 Mar; 47(3):537-546. PubMed ID: 31776631
[TBL] [Abstract][Full Text] [Related]
3. Chemokine Receptor 4-Targeted 68Ga-Pentixafor PET/CT in Response Assessment of Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma: Comparison to 18F-FDG PET/CT.
Pan Q; Cao X; Luo Y; Li J; Li F
Clin Nucl Med; 2021 Sep; 46(9):732-737. PubMed ID: 34172595
[TBL] [Abstract][Full Text] [Related]
4. 11C-Methionine-PET in Multiple Myeloma: Correlation with Clinical Parameters and Bone Marrow Involvement.
Lapa C; Knop S; Schreder M; Rudelius M; Knott M; Jörg G; Samnick S; Herrmann K; Buck AK; Einsele H; Lückerath K
Theranostics; 2016; 6(2):254-61. PubMed ID: 26877783
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of
Kuyumcu S; Isik EG; Tiryaki TO; Has-Simsek D; Sanli Y; Buyukkaya F; Özkan ZG; Kalayoglu-Besisik S; Unal SN
Ann Nucl Med; 2021 Oct; 35(10):1147-1156. PubMed ID: 34185263
[TBL] [Abstract][Full Text] [Related]
6.
Luo Y; Cao X; Pan Q; Li J; Feng J; Li F
J Nucl Med; 2019 Dec; 60(12):1724-1729. PubMed ID: 31101745
[No Abstract] [Full Text] [Related]
7.
Hemrom A; Tupalli A; Alavi A; Kumar R
PET Clin; 2022 Jul; 17(3):415-430. PubMed ID: 35717100
[TBL] [Abstract][Full Text] [Related]
8. Correlation Between Baseline 18F-FDG PET/CT Findings and CD38- and CD138-Expressing Myeloma Cells in Bone Marrow and Clinical Parameters in Patients with Multiple Myeloma.
Cengiz A; Arda HÜ; Döğer F; Yavaşoğlu İ; Yürekli Y; Bolaman AZ
Turk J Haematol; 2018 Aug; 35(3):175-180. PubMed ID: 29806594
[TBL] [Abstract][Full Text] [Related]
9. Imaging Inflammation in Atherosclerosis with CXCR4-Directed [
Lu X; Calabretta R; Wadsak W; Haug AR; Mayerhöfer M; Raderer M; Zhang X; Li J; Hacker M; Li X
Life (Basel); 2022 Jul; 12(7):. PubMed ID: 35888127
[TBL] [Abstract][Full Text] [Related]
10. 11C-choline vs. 18F-FDG PET/CT in assessing bone involvement in patients with multiple myeloma.
Nanni C; Zamagni E; Cavo M; Rubello D; Tacchetti P; Pettinato C; Farsad M; Castellucci P; Ambrosini V; Montini GC; Al-Nahhas A; Franchi R; Fanti S
World J Surg Oncol; 2007 Jun; 5():68. PubMed ID: 17584499
[TBL] [Abstract][Full Text] [Related]
11. Physiological uptake of 18F-FDG in the vertebral bone marrow in healthy adults on PET/CT imaging.
Shen G; Liang M; Su M; Kuang A
Acta Radiol; 2018 Dec; 59(12):1487-1493. PubMed ID: 29486597
[TBL] [Abstract][Full Text] [Related]
12. 68Ga-Pentixafor PET/CT Improves the Detection of Recurrent Myeloma in the Temporal Bone Masked by the Physiological 18F-FDG Uptake of the Brain and Extraocular Muscles.
Pan Q; Luo Y; Cao X; Li J
Clin Nucl Med; 2022 Apr; 47(4):e348-e350. PubMed ID: 35020649
[TBL] [Abstract][Full Text] [Related]
13. [
Lapa C; Schreder M; Schirbel A; Samnick S; Kortüm KM; Herrmann K; Kropf S; Einsele H; Buck AK; Wester HJ; Knop S; Lückerath K
Theranostics; 2017; 7(1):205-212. PubMed ID: 28042328
[TBL] [Abstract][Full Text] [Related]
14. (18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate.
Sachpekidis C; Mai EK; Goldschmidt H; Hillengass J; Hose D; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A
Clin Nucl Med; 2015 Jun; 40(6):e300-7. PubMed ID: 25783508
[TBL] [Abstract][Full Text] [Related]
15. 32nd International Austrian Winter Symposium : Zell am See, the Netherlands. 20-23 January 2016.
Langsteger W; Rezaee A; Loidl W; Geinitz HS; Fitz F; Steinmair M; Broinger G; Pallwien-Prettner L; Beheshti M; Imamovic L; Beheshti M; Rendl G; Hackl D; Tsybrovsky O; Steinmair M; Emmanuel K; Moinfar F; Pirich C; Langsteger W; Bytyqi A; Karanikas G; Mayerhöfer M; Koperek O; Niederle B; Hartenbach M; Beyer T; Herrmann K; Czernin J; Rausch I; Rust P; DiFranco MD; Lassen M; Stadlbauer A; Mayerhöfer ME; Hartenbach M; Hacker M; Beyer T; Binzel K; Magnussen R; Wei W; Knopp MU; Flanigan DC; Kaeding C; Knopp MV; Leisser A; Nejabat M; Hartenbach M; Kramer G; Krainer M; Hacker M; Haug A; Lehnert W; Schmidt K; Kimiaei S; Bronzel M; Kluge A; Wright CL; Binzel K; Zhang J; Wuthrick E; Maniawski P; Knopp MV; Blaickner M; Rados E; Huber A; Dulovits M; Kulkarni H; Wiessalla S; Schuchardt C; Baum RP; Knäusl B; Georg D; Bauer M; Wulkersdorfer B; Wadsak W; Philippe C; Haslacher H; Zeitlinger M; Langer O; Bauer M; Feldmann M; Karch R; Wadsak W; Zeitlinger M; Koepp MJ; Asselin MC; Pataraia E; Langer O; Zeilinger M; Philippe C; Dumanic M; Pichler F; Pilz J; Hacker M; Wadsak W; Mitterhauser M; Nics L; Steiner B; Hacker M; Mitterhauser M; Wadsak W; Traxl A; Wanek T; Kryeziu K; Mairinger S; Stanek J; Berger W; Kuntner C; Langer O; Mairinger S; Wanek T; Traxl A; Krohn M; Stanek J; Filip T; Sauberer M; Kuntner C; Pahnke J; Langer O; Svatunek D; Denk C; Wilkovitsch M; Wanek T; Filip T; Kuntner-Hannes C; Fröhlich J; Mikula H; Denk C; Svatunek D; Wanek T; Mairinger S; Stanek J; Filip T; Fröhlich J; Mikula H; Kuntner-Hannes C; Balber T; Singer J; Fazekas J; Rami-Mark C; Berroterán-Infante N; Jensen-Jarolim E; Wadsak W; Hacker M; Viernstein H; Mitterhauser M; Denk C; Svatunek D; Sohr B; Mikula H; Fröhlich J; Wanek T; Kuntner-Hannes C; Filip T; Pfaff S; Philippe C; Mitterhauser M; Hartenbach M; Hacker M; Wadsak W; Wanek T; Halilbasic E; Visentin M; Mairinger S; Stieger B; Kuntner C; Trauner M; Langer O; Lam P; Aistleitner M; Eichinger R; Artner C; Eidherr H; Vraka C; Haug A; Mitterhauser M; Nics L; Hartenbach M; Hacker M; Wadsak W; Kvaternik H; Müller R; Hausberger D; Zink C; Aigner RM; Cossío U; Asensio M; Montes A; Akhtar S; Te Welscher Y; van Nostrum R; Gómez-Vallejo V; Llop J; VandeVyver F; Barclay T; Lippens N; Troch M; Hehenwarter L; Egger B; Holzmannhofer J; Rodrigues-Radischat M; Pirich C; Pötsch N; Rausch I; Wilhelm D; Weber M; Furtner J; Karanikas G; Wöhrer A; Mitterhauser M; Hacker M; Traub-Weidinger T; Cassou-Mounat T; Balogova S; Nataf V; Calzada M; Huchet V; Kerrou K; Devaux JY; Mohty M; Garderet L; Talbot JN; Stanzel S; Pregartner G; Schwarz T; Bjelic-Radisic V; Liegl-Atzwanger B; Aigner R; Stanzel S; Quehenberger F; Aigner RM; Marković AK; Janković M; Jerković VM; Paskaš M; Pupić G; Džodić R; Popović D; Fornito MC; Familiari D; Koranda P; Polzerová H; Metelková I; Henzlová L; Formánek R; Buriánková E; Kamínek M; Thomson WH; Lewis C; Thomson WH; O'Brien J; James G; Notghi A; Huber H; Stelzmüller I; Wunn R; Mandl M; Fellner F; Lamprecht B; Gabriel M; Fornito MC; Leonardi G; Thomson WH; O'Brien J; James G; Hudzietzová J; Sabol J; Fülöp M
EJNMMI Res; 2016 Apr; 6(Suppl 1):32. PubMed ID: 27090254
[TBL] [Abstract][Full Text] [Related]
16. Chemokine Receptor CXCR4-Targeted PET/CT With 68Ga-Pentixafor Shows Superiority to 18F-FDG in a Patient With Waldenström Macroglobulinemia.
Luo Y; Pan Q; Feng J; Cao X; Li F
Clin Nucl Med; 2018 Jul; 43(7):548-550. PubMed ID: 29742593
[TBL] [Abstract][Full Text] [Related]
17. Comparison of 11C-Choline and 11C-Methionine PET/CT in Multiple Myeloma.
Lapa C; Kircher M; Da Via M; Schreder M; Rasche L; Kortüm KM; Einsele H; Buck AK; Hänscheid H; Samnick S
Clin Nucl Med; 2019 Aug; 44(8):620-624. PubMed ID: 31274607
[TBL] [Abstract][Full Text] [Related]
18. [68Ga]Ga-Pentixafor PET/MRI for CXCR4 Imaging of Chronic Lymphocytic Leukemia: Preliminary Results.
Mayerhoefer ME; Jaeger U; Staber P; Raderer M; Wadsak W; Pfaff S; Kornauth C; Senn D; Weber M; Wester HJ; Skrabs C; Haug A
Invest Radiol; 2018 Jul; 53(7):403-408. PubMed ID: 29642081
[TBL] [Abstract][Full Text] [Related]
19. 68Ga-Pentixafor PET/MRI for Treatment Response Assessment in Mantle Cell Lymphoma: Comparison Between Changes in Lesion CXCR4 Expression on PET and Lesion Size and Diffusivity on MRI.
Mayerhoefer ME; Raderer M; Weber M; Lamm W; Kiesewetter B; Hacker M; Nics L; Schmitl S; Leithner D; Wester HJ; Haug A
Clin Nucl Med; 2023 Jul; 48(7):557-562. PubMed ID: 37272977
[TBL] [Abstract][Full Text] [Related]
20. Burkitt Lymphoma/Leukemia Presented on 68Ga-Pentixafor and 18F-FDG PET/CT.
Chen Z; Xue Q; Huang C; Yao S; Miao W
Clin Nucl Med; 2022 Jan; 47(1):98-100. PubMed ID: 34115701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
